-Soizic Daniel Researcher Activity Profile

Research Author Detailed Information 

Soizic Daniel Publication Rate By Year

Soizic Daniel has published 1 paper(s) in 2002, 2 paper(s) in 2003, 1 paper(s) in 2004, 1 paper(s) in 2005, 1 paper(s) in 2006, 2 paper(s) in 2007, for a total of 8 research publications in total.

Soizic S Daniel Author Information

LAST NAME: daniel

FIRST NAME: soizic

INITIALS: S

AFFILIATION:

Papers

Soizic Daniel's Publication Record

1. A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: modulation of cell migration and proliferation. Year Published: 2007
Department of Surgery, Division of Vascular Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.
2. Comparison of gene silencing in human vascular cells using small interfering RNAs. Year Published: 2007
Department of Surgery, Division of Vascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
3. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Year Published: 2002
Department of Surgery and Medicine, Immunobiology Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Avenue, Boston, MA 02215, USA.
4. Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. Year Published: 2003
Immunobiology Research Center, Department of Surgery and Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. sgrey@caregroup.harvard.edu
5. A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis. Year Published: 2003
Immunobiology Research Center, Department of Surgery and Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass 02215, USA.
6. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Year Published: 2004
Department of Surgery and Medicine, 99 Brookline Ave, Boston MA 02215, USA.
7. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells. Year Published: 2005
Division of Vascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
8. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. Year Published: 2006
The Immunobiology Research Center, Harvard Medical School, Boston Massachusetts, USA.